Leading Molecular Diagnostics Company BillionToOne Announces Three Executive Appointments Amid Rapid Growth | PR Newswire [Video]

Category-Defining Company Adds Senior Leadership in Finance, Business Development, and Technology

, /PRNewswire/ — BillionToOne, a next-generation molecular diagnostics company, announces three new executive appointments to support its expanding prenatal screening and oncology diagnostics business. Judy Wong joins as Vice President, Controller; Alex Bisignano as Vice President of Business Development; and Susan Lin as Vice President of Information Systems. The increased investment in leadership reinforces the company’s goals to significantly build and scale BillionToOne, ultimately reaching more patients and providers.

The appointments follow a series of strategic financial milestones for BillionToOne, including a $130 million Series D round at a $1 billion+ valuation in June 2024 and a recent $140 million non-dilutive financing agreement. With these investments, bringing total capital raised to nearly $400 million, BillionToOne has secured substantial resources to accelerate its commercial expansion. The company has demonstrated strong market momentum, growing from $0 to $150 millionin annual recurring revenue over the …